The barbiturates are derivatives of uracil, a component of the nucleic acids. They have been used extensively in medical and biological studies for many years, but the molecular basis of their mode of action is unknown. Recent infrared studies have shown that the barbiturates have a high selective affinity for forming hydrogen-bonded complexes with molecules containing adenine.I This phenomenon may be related to the way in which the barbiturates act in living systems. Selectivity in hydrogen-bond formation is an important component of biological organization, especially in the nucleic acids. The purine and pyrimidine components of these molecules have an affinity for each other. Derivatives of adenine form hydrogen bonds selectively with thymine or uracil derivatives, whereas guanine derivatives bond selectively with cytosine derivatives.24 These effects, called electronic complementarity,5 reinforce the geometrical complementarity which is found as a structural component of the double-helical form of the nucleic acids. In the infrared study,' it was found that association constants for hydrogen bonding between the barbiturates and adenine derivatives are an order of magnitude greater than those found between uracil and adenine derivatives. In the course of that investigation, intermolecular crystalline complexes were observed to form between a variety of barbiturates and several different adenine derivatives. Here we report the structure of the intermolecular complex containing one phenobarbital and two 8-bromo-9-ethyladenine molecules. It is found that one adenine derivative is hydrogen-bonded to the barbiturate ring using the same bonds found between the adenine and thymine pair in the double-helical form of DNA.6 The other adenine derivative is hydrogenbonded to a second site on the same barbiturate ring. In addition, the adenine derivatives are hydrogen-bonded to each other using the same system of hydrogen bonds found in the helical form of polyadenylic acid.7
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Materials and Methods.-Commercial phenobarbital tablets were dissolved in chloroform and the phenobarbital was purified by solvent extraction. 8-Bromo-9-ethyladenine was purchased from Cyclo Chemical Company, Los Angeles, California. Phenobarbital and 8-bromo-9-ethyladenine were initially dissolved separately in chloroform solutions. When the two solutions were mixed together in an equimolar ratio, a white precipitate formed which was collected on filter paper and dissolved in hot water. The aqueous solution was allowed to cool and then evaporate at room temperature until well-formed, clear prismatic crystals appeared. The crystals had edges over a millimeter in length. Individual crystals were isolated and dissolved in water. The ultraviolet absorption spectrum revealed the presence of the two components in the solution. However, due to the character of the phenobarbital absorption spectrum, it was not possible to determine the mole ratio of the constituents. The unit-cell and space-group determinations were carried out with Weissenberg and precession cameras, and the density of the crystals was measured by the flotation tech- nique. The density measurements were compatible with either a 1:2 or 2:1 complex. Three-dimensional X-ray diffraction data were collected on a Picker FACS-1 diffractometer system which was computer-controlled. The data were collected out to a 20 value of 100°. Slightly over 3000 independent reflections were registered with copper Ka radiation, which was monochromatized by a highly oriented graphite monochrometer. Intensities were measured by the 20 scan technique. The intensity data were reduced to structure factors (F) by correcting for the Lorentz-polarization factor. The crystal measured approximately 0.2 by 0.3 by 0.7 mm, and no corrections were made for X-ray absorption.
Results.-The molecules crystallized in a triclinic lattice. The normalized structure factors (E) were calculated from the structure factors and were used to calculate a three-dimensional sharpened (E2) Patterson function. The Patterson map revealed two very heavy peaks and two peaks of half their height. This would be anticipated if there were two bromine atoms in the asymmetric unit and a center of symmetry. From this and the statistics of the normalized structure factors8 it could be concluded that the space group was P1 rather than P1. The existence of two bromine atoms in the asymmetric unit implied that the unit cell contained two phenobarbital molecules and four molecules of 8-bromo-9-ethyladenine; thus the crystal is a 1:2 complex. The unit-cell and space-group data for the complex of phenobarbital and 8-bromo-9-ethyladenine are listed in Table 1 together with the observed and calculated densities.
These intense peaks were used to assign trial coordinates to the two bromine atoms in an asymmetric unit. A trial electron density map was calculated in which the phases were strongly determined by the bromine atoms. Only those structure factors were used in which IF (obs)j was large and F (calc)/F (obs) > kNbromine/Ntotal, where k is a constant (0.6) and N is number of electrons. The initial electron density map revealed unambiguously 32 out of the total of 43 nonhydrogen atoms in the asymmetric unit. The atoms not located included those in the phenyl and ethyl groups of phenobarbital and the ethyl group of one adenine and the terminal carbon atom of the ethyl group in the other adenine derivative. Another electron density map was calculated using all the atoms which had been located and a criterion similar to that used in choosing the phases. This map showed all of the remaining atoms except ethyl carbons of phenobarbital. These emerged in the difference Fourier map calculated after two cycles of least-squares refinement of isotropic temperature factors and coordinates. At this stage the residual factor was 21 per cent. Three cycles of least-squares refinement were carried out, two of which utilized isotropic temperature factors and one anisotropic temperature factors.9 The final residual was 8.4 per cent. At this stage, 13 of the 28 hydrogens in the structure could be seen in a difference Fourier map. The coordinates of all the atoms other than hydrogen are listed in Table 2 , together with the numbering system.
Description of the Structure.-The molecules crystallize into elongated lath- Figure 2 . Figure 2a shows the normal hydrogen bonding found between adenine and thymine in double-stranded DNA. 6 In that base pair the carbonyl 04 and N3 of the thymine ring are connected by hydrogen bonds to the amino group and to N1 of the adenine ring. This pairing is analogous to the hydrogen bonding between phenobarbital and 8-bromo-9-ethyladenine (1) shown in Figure 2a .
The barbiturates may be also looked upon as analogues of pseudouridine, a common constituent of transfer RNA which has ribose attached to C5 rather than N1. Because of this, N1 of the pyrimidine ring has a proton bonded to it and this, together with the carbonyl 02, provides a second site which can be used for hydrogen-bond formation (Fig. 2b) . A second type of hydrogen bonding in the crystal is analogous to the binding of adenine to pseudouracil. In this manner, adenine (II) in Figure 1 is attached to phenobarbital through two hydrogen bonds between the amino group and N1 of adenine and the carbonyl 02 and N1 of phenobarbital.
The third type of hydrogen bonding seen in the structure is the association between the adenine derivatives. In the crystal this involves a pairing between the amino group and N7 around a center of symmetry (Fig 2c) . There are two different pairings of this type in the crystal. One of these pairs (I-I) is held together with two hydrogen bonds of length 3.09 A each, the other (II-II) has bonds of 3.02 A. This hydrogen-bonding arrangement is the same as that found in crystals of adenine hydrochloride'0 or in the helical form of polyadenylic acid in which the adenine is protonated on the N1 position.7 This is shown in Figure 2c .
The extended hydrogen-bonded array deviates slightly from planarity. If the array shown in Figure 1 were completely planar, the bromine atom of 8- bromo-9-ethyladenine (II) would be 2.4 A from the hydrogen atom attached to C2 of the adjoining adenine (I) residue. The sum of the van der Waals radii of these atoms is close to 2.95 A. Adjacent adenine rings are therefore staggered so that they lie on either side of the mean plane of the extended lath shown in 1. This displacement from the mean plane is partially reflected in the dihedral angles between the hydrogen-bonded bases.
All of the atoms in the adenine derivative, with the exception of the terminal carbon atoms of the ethyl side chain, are coplanar within 0.12 A in adenine (I) and within 0.02 A in adenine (II). In phenobarbital, C5 is 0.35 A out of the least-squares plane of the pyrimidine ring. A similar displacement has been observed in alloxan" (5,5-dihydroxyl barbituric acid), but not in other barbiturates such as barbital or amobarbital.'2 The dihedral angle between phenobarbital and adenine (I) is 17.50,whereas that between phenobarbital and adenine (II) is 16.3°. Crystals of hydrogen-bonded purines and pyrimidines often have small dihedral angles between them,'3 although they are usually somewhat smaller than those observed in the present structure.
The hydrogen bond between carbonyl 04 of phenobarbital and the amino group of adenine (I) has a length of 3.19 A, which is longer than normal. The two N H . .. N hydrogen bonds between phenobarbital and adenine have lengths of 2.78 and 2.80 A, which is slightly shorter than normal. The remaining hydrogen bond lengths are in the range of values normally seen.
Discussion.-To date, seven cocrystals have been found, involving four different adenine derivatives and three different barbiturates. Thus the phenomenon of cocrystallization appears to be a general one and is clearly related to the very high association constants for hydrogen bonding which have been determined from solution studies.' This is the first determination of the structure of an intermolecular complex between a barbiturate and an adenine derivative. The structure has some unusual features. It is the first case in which a pyrimidine derivative has cocrystallized with two purine derivatives. The adenine molecule has two sites capable of forming pairs of hydrogen bonds with thymine or uracil derivatives. These involve the amino group and either N1 or N7. The structures of several intermolecular complexes of adenine and uracil derivatives have been determined; most of them have 1:1 stoichiometry,'3 and they usually involve the N7 rather than N1 site. However, intermolecular complexes containing derivatives of 2,6-diamino purine have cocrystallized with two uracil derivatives on both N1 and N7 sites.'4 Uracil or thymine derivatives normally have only one site available for hydrogen-bond formation when there is a substituent on the glycosidic N1 atom. However, the barbiturates have side chains attached to the C5 position and a proton is found on N1. This allows the barbiturate to form the double set of hydrogen-bonded structures seen in the present crystal. It is interesting to note, however, that some of the other barbiturateadenine complexes form 1:1 crystals. Their structure will be reported elsewhere. 15 Both of the adenine derivatives are hydrogen-bonded to the barbiturate ring through Ni of adenine rather than N7. This is not surprising because the bromine atom blocks the formation of a hydrogen bond between N7 of adenine and N3 of uracil due to steric hindrance. When the uracil carbonyl 02 is in van der Waals contact with the bromine atom on C8, the uracil N3 is approximately 3.5 A from the adenine N7. Thus a hydrogen bond cannot form. However, the bromine does not block the formation of the hydrogen-bonded adenine pair that is a component of helical polyadenylic acid.7 It is interesting in the present context that there are two different sets of adenine-adenine hydrogen bonds involving molecules in the pairs I-I and II-II with slightly different hydrogen-bonding distances.
The barbiturates are highly active molecules in biological systems. In addition to their central nervous system activity, they also modify a wide variety of biological systems. Indeed, one of the puzzling features concerning their pharmacological action is the large number of different systems affected by them. The strong interaction observed between barbiturates and several adenine derivatives has led to a theory regarding the molecular mechanism underlying the mode of action of the barbiturates.' 16 The suggestion put forward is that the barbiturates specifically bind and inactivate a variety of molecules containing adenine, including coenzymes and adenosine 5'-triphosphate. An important component of this interaction is a lipophilic environment which aids in the binding of the barbiturate side chains. Thus, many of the affected systems are imbedded in membranes. The postulated inactivation mechanism involves the formation of specific hydrogen bonds between various adenine-containing compounds and the barbiturates. The present crystal structure analysis may be regarded as a prototype of this postulated interaction in that it illustrates the two potential kinds of binding of a barbiturate to molecules containing adenine. These interactions may not be too different from the kind of hydrogen bonding to adeninecontaining coenzymes or nucleotides which is believed to take place in biological membranes or on the surface of selected enzymes.
Summary.-An intermolecular crystalline complex forms between 8-bromo-9-ethyladenine and phenobarbital. The structure of this complex has been solved by X-ray diffraction analysis. The phenobarbital forms two different sets of hydrogen bonds with the two adenine derivatives. These hydrogen-bonded triplets are joined together by means of adenine-adenine pairs of hydrogen bonds. Some of these sets of hydrogen bonds are analogous to those which occur in helical polynucleotides. The hydrogen bonding between barbiturates and adenine derivatives is a general phenomenon which may be related to the mode of action of barbiturates in biological systems.
